Trastuzumab Deruxtecan Gets Priority Review for Previously Treated HER2-Mutant Metastatic NSCLC
The FDA has granted Priority Review to fam-trastuzumab deruxtecan-nxki to treat adults with previously treated HER2-mutant metastatic NSCLC.
Oncology
Trial Evaluating Tiragolumab Combo for Extensive-Stage SCLC Misses Endpoint
Tiragolumab is a monoclonal antibody that works by binding to TIGIT, a protein receptor on immune cells, and suppresses the immune response to cancer.
BMI a Factor in Risk of Thromboembolic Events With Peripherally Inserted Central Catheters
A study sought to determine whether overweight/obesity is a factor in the development of thrombosis in cancer patients with peripherally inserted central catheters.
Applying Artificial Intelligence in the Bronchoscopy Suite
A team of investigators studied an artificial intelligence model’s accuracy in classification of images obtained from rapid on-site examination of EBUS-TBNA smears in the bronchoscopy suite.
Higher Mortality Among COVID-19 Patients with Cancer
Investigators compared the clinical course, risk factors, and outcomes of cancer patients with COVID-19 with non-cancer patients with COVID-19.
- Loading...
Loading...
Next post in Lung Infection
Loading... 
Loading...